The short version
- The low-FODMAP diet has three stages — restriction, reintroduction and personalisation — and clinical effectiveness is achieved with dietitian-led education.
- In the CARIBS trial, 76% of people on a low-FODMAP diet plus traditional dietary advice responded at four weeks, against 58% on optimised medical treatment.
- In a 69-person randomised trial, low-FODMAP restriction lowered faecal Actinobacteria to about 1.9% against 4.2% in controls and cut faecal butyrate from 609 to 387, and the authors concluded strict long-term use should not be advised.
- Adding 1.4 g a day of beta-galactooligosaccharide alongside the diet did not prevent the fall in bifidobacteria, so a prebiotic capsule does not buy back the microbial cost.
- Evidence for the reintroduction and personalisation stages is limited and of lower quality than the restriction evidence, with wheat, onion, garlic, pulses and milk the commonly identified triggers.
The most common way to get this wrong is also the most understandable. You cut out the FODMAPs, you feel dramatically better within a fortnight, and you conclude that you have found your answer and should stay there. That is stage one of three, and stopping at stage one is the failure mode this whole protocol was designed to avoid.
FODMAPs are fermentable oligosaccharides, disaccharides, monosaccharides and polyols — short-chain carbohydrates that are poorly absorbed in the small intestine, draw water in, and get fermented further down. Wheat, onion, garlic, pulses, milk, and a long list of fruits are the usual suspects. The diet is a second-line dietary management strategy for IBS, and Lomer's 2024 review describes it in three explicit stages: restriction, reintroduction and personalisation.
It works, and that is the easy part
Systematic reviews consistently report a better symptom response than control diets, and a network analysis puts it ahead of other dietary treatments for IBS. The most striking single result is from CARIBS, where 294 people with moderate-to-severe IBS were randomised to a low-FODMAP diet plus traditional dietary advice, a low-carbohydrate diet, or optimised medical treatment matched to their predominant symptom. At four weeks, 76% of the low-FODMAP group had responded against 58% on medication.
That is a dietary protocol outperforming a doctor's best pharmacological choice, and it is the reason nobody serious argues about whether restriction works.
What restriction costs while it is working
Wilson and colleagues ran a three-arm randomised trial in 69 IBS patients: a sham diet with placebo, a low-FODMAP diet with placebo, or a low-FODMAP diet plus 1.4 g a day of beta-galactooligosaccharide, a prebiotic added specifically to try to protect the bifidobacteria.
The symptom result was good — adequate relief in 16 of 24 (67%) on the diet plus prebiotic against 7 of 23 (30%) on sham, an odds ratio of 4.6. The microbial result was not. The added prebiotic did not prevent the decline in bifidobacteria. Actinobacteria fell to 1.9% on the diet alone and 1.8% on diet plus prebiotic, against 4.2% in the control group. Faecal butyrate fell from 609 in controls to 387 and 346 respectively.
The authors' own conclusion is the sentence to take away: strict long-term use should not be advised. And note the practical implication — you cannot buy your way around the microbial cost with a prebiotic capsule. That was tested. It did not work.
Stage two is the one everyone skips
Reintroduction exists to find out which FODMAPs are actually yours. Most people are not reactive to all of them, and the point of the exercise is to end up eating the widest diet that keeps you comfortable — not the narrowest one that does.
Lomer is candid that this is where the evidence thins: research on reintroduction and personalisation is limited and of lower quality than the restriction research. The common triggers identified are wheat, onion, garlic, pulses and milk. That is a short enough list that finding your two or three and eating everything else is a realistic outcome.
Do it with a dietitian if you possibly can
Clinical effectiveness is achieved with dietitian-led education, and the alternative delivery routes — webinars, apps, leaflets — remove the personalised element. Lomer notes they may be less acceptable to patients and may introduce safety concerns in terms of nutritional adequacy. That is polite phrasing for: a complicated exclusion diet run from an app, with no end date and nobody checking, is how people end up undernourished and more frightened of food than when they started.
There is also a practical interaction worth flagging. A lot of high-FODMAP foods are also the high-fibre ones, so restriction can make chronic constipation worse while it is improving the pain and bloating. If your predominant problem is not going, tell whoever is guiding you before you start.
What we would tell you
Four to six weeks of restriction is the test, not the treatment. If it has not helped by then, it is not your answer and staying on it is pure cost. If it has helped, that is the signal to start reintroducing, one FODMAP group at a time, and to be genuinely pleased every time something turns out to be fine.
We sell nothing for this, and there is nothing to sell. There is no low-FODMAP supplement, the prebiotic rescue was tested and did not protect the bifidobacteria, and a protocol whose whole purpose is to be temporary makes a poor subscription. If your symptoms are IBS-shaped, peppermint oil is the shelf item with the best trial evidence, and the diet work is still the bigger lever. Finally, work out what causes your bloating before you restrict anything — coeliac disease has to be excluded first, and it cannot be excluded once you have already cut out wheat.
Good questions
How long should I stay on the restriction phase?
Four to six weeks, then reintroduce. Restriction is a diagnostic test, not a treatment, and the trial that measured the microbial cost concluded that strict long-term use should not be advised. If it has not helped in six weeks it is not your answer, and continuing is cost without benefit. If it has helped, that is your cue to start adding foods back one group at a time.
Can I do the low-FODMAP diet without a dietitian?
You can, and it is measurably worse. Clinical effectiveness in the literature comes from dietitian-led education, and app or leaflet delivery removes the personalisation and raises documented concerns about nutritional adequacy. If a dietitian is genuinely out of reach, at minimum set an end date for restriction before you begin, and write down the reintroduction plan on day one.
Is there a supplement that makes the low-FODMAP diet easier?
No, and one obvious candidate was tested and failed. Adding 1.4 g a day of a beta-galactooligosaccharide prebiotic alongside the diet did not prevent the drop in bifidobacteria that restriction causes. We sell nothing for this because there is nothing worth selling you for it.
Will the low-FODMAP diet damage my gut microbiome permanently?
The measured changes are real and were seen at four weeks, and nothing in that trial suggests they are permanent once you reintroduce. Faecal Actinobacteria and butyrate both fell during restriction. That is precisely why the protocol has a reintroduction stage and why the researchers advised against staying strict long term.
Can low-FODMAP make constipation worse?
It can. Many high-FODMAP foods are also high-fibre foods, so cutting them can improve pain and bloating while making stools harder to pass. If not going is your main complaint, say so before you start, because the protocol needs adjusting rather than following as printed.
Should I get tested for coeliac disease before starting?
Yes, and this matters more than anything else on this page. Coeliac serology is unreliable once you have already cut wheat out, so starting a low-FODMAP diet before testing can make a real diagnosis much harder to reach. Get the blood test done first, on your normal diet.
Sources
- Lomer MCE. The low FODMAP diet in clinical practice: where are we and what are the long-term considerations? Proc Nutr Soc, 2024. View study
- Nybacka S, Törnblom H, Josefsson A, et al. A low FODMAP diet plus traditional dietary advice versus a low-carbohydrate diet versus pharmacological treatment in irritable bowel syndrome (CARIBS): a single-centre, single-blind, randomised controlled trial. Lancet Gastroenterol Hepatol, 2024. View study
- Wilson B, Rossi M, Kanno T, et al. β-Galactooligosaccharide in Conjunction With Low FODMAP Diet Improves Irritable Bowel Syndrome Symptoms but Reduces Fecal Bifidobacteria. Am J Gastroenterol, 2020. View study
- Moshiree B, Drossman D, Shaukat A. AGA Clinical Practice Update on Evaluation and Management of Belching, Abdominal Bloating, and Distention: Expert Review. Gastroenterology, 2023. View study
These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.
